Hepatocellular carcinoma in central Sydney: a 10 year review of patients seen in a medical oncology department

Table 1 Countries of birth of cohort

Country of Birth	No.
Australia	26
Egypt	3
Europe	11
India	1
Pacific Islands	1
Southeast Asia	20
Unknown	1
Total	63

Table 2 Breakdown of established aetiological factors in cohort

Alcohol	10
Chronic autoimmune hepatitis	3
Hepatitis B	21
Hepatitis C	5
Hepatitis B + C	3
Haemochromatosis	3
Unknown	23
Total	63

Table 3 Summary of treatments received for hepatocellular carcinoma

Treatment	Number of patients (%)	Number responding (%)	Median time to progression (weeks)
Observation	20 (30)
Surgery	16 (25)	16 (100)	43
Chemoembolization	11 (17)	6 (54)	25
Systemic chemotherapy	12 (19)	2 (27)	26
Tamoxifen	25 (40)	1 (4)	44